Low Dose G-CSF to Augment Host Defense and Counteract Progression of Sepsis

作者: M. Weiss , E. M. Schneider , P. Radermacher

DOI: 10.1007/978-3-642-80053-5_14

关键词:

摘要: Multiple trauma patients and undergoing major surgical operations are predisposed to life-threatening sepsis by an apparently acquired immunological deficiency, which is accompanied a high mortality rate (40 60%) [1]. Neutrophils represent the first line of defense against invading bacteria. However, impaired neutrophil function has been reported in severely injured [2] during early septic shock [3]. Surgery resulted further depression with intra-peritoneal infections [4]. In these patients, relapses were associated diminution prior any clinical evidence for infection Thus, at risk or might benefit from prophylactic augmentation restoration function. Unfortunately, until recently, there no choice counteract granulocyte dysfunctions have described posttraumatic [2]. mice, recombinant human colony-stimulating factor (rhG-CSF) improved survival well-established model [5]. G-CSF one important hemopoietic factors plays central role precursor cell proliferation differentiation into neutrophils [6]. addition stimulation maturation, enhances variety functions neutrophils, including chemotaxis [7], superoxide generation [8], bactericidal [9] phagocytic activity [9]. Moreover, may beneficial effects on feedback regulation cytokines [5, 10]. activate hand provide anti-inflammatory effect other.

参考文章(57)
Schmitz S, Brusis J, Franke H, Wichmann He, Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis Experimental Hematology. ,vol. 21, pp. 755- 760 ,(1993)
R M Strieter, S L Kunkel, Acute lung injury: the role of cytokines in the elicitation of neutrophils. Journal of Investigative Medicine. ,vol. 42, pp. 640- 651 ,(1994)
TW Kuijpers, AT Tool, CE van der Schoot, LA Ginsel, JJ Onderwater, D Roos, AJ Verhoeven, Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood. ,vol. 78, pp. 1105- 1111 ,(1991) , 10.1182/BLOOD.V78.4.1105.BLOODJOURNAL7841105
Sitter H, Lorenz W, Celik I, Schneider C, Neumann K, Reimund Kp, Weitzel F, Kurnatowski M, Heiske A, Mannheim W, Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery. ,vol. 116, pp. 925- 934 ,(1994)
A Lindemann, F Herrmann, W Oster, G Haffner, W Meyenburg, LM Souza, R Mertelsmann, Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood. ,vol. 74, pp. 2644- 2651 ,(1989) , 10.1182/BLOOD.V74.8.2644.2644
JM Wang, ZG Chen, S Colella, MA Bonilla, K Welte, C Bordignon, A Mantovani, Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood. ,vol. 72, pp. 1456- 1460 ,(1988) , 10.1182/BLOOD.V72.5.1456.1456
Marcel Leist, Thomas Hartung, Marcus Niehörster, Stefan Uhlig, Gisa Tiegs, Ingrid Görgen, Albrecht Wendel, Frank Weitzel, Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. Journal of Immunology. ,vol. 149, pp. 918- 924 ,(1992)
K S Kilgore, J S Warren, J P Shen, B F Miller, P A Ward, Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. Journal of Immunology. ,vol. 155, pp. 1434- 1441 ,(1995)